메뉴 건너뛰기




Volumn 10, Issue 10, 2009, Pages 1587-1603

Pharmacotherapy of coronary atherosclerosis

Author keywords

Animal models; Atherosclerosis; Human pathology; Imaging; Statins

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; DARAPLADIB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN; JIT 70545; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TORCETRAPIB; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 67650451372     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902988494     Document Type: Review
Times cited : (22)

References (102)
  • 1
    • 33644876621 scopus 로고    scopus 로고
    • Apolipoprotein B versus non-high-density lipoprotein cholesterol: And the winner is
    • DOI 10.1161/CIRCULATIONAHA.105.583336, PII 0000301720051129000002
    • Sniderman AD. Apolipoprotein B versus nonhigh-density lipoprotein cholesterol: and the winner is. Circulation 2005;112:3366-3367 (Pubitemid 43739547)
    • (2005) Circulation , vol.112 , Issue.22 , pp. 3366-3367
    • Sniderman, A.D.1
  • 2
    • 35148815698 scopus 로고    scopus 로고
    • Apolipoproteins A-I and B: Biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease
    • Olofsson SO, Wiklund O, Boren J. Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 2007;3:491-502 (Pubitemid 47542610)
    • (2007) Vascular Health and Risk Management , vol.3 , Issue.4 , pp. 491-502
    • Olofsson, S.-O.1    Wiklund, O.2    Boren, J.3
  • 3
    • 50649115698 scopus 로고    scopus 로고
    • Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)
    • Holme I, Cater NB, Faergeman O, et al. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL). Ann Med 2008;1-9
    • (2008) Ann Med , pp. 1-9
    • Holme, I.1    Cater, N.B.2    Faergeman, O.3
  • 7
    • 0037126526 scopus 로고    scopus 로고
    • Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
    • Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 8
    • 33646829645 scopus 로고    scopus 로고
    • Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials
    • DOI 10.1136/bmj.38793.468449.AE
    • Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ 2006;332:1115-1124 (Pubitemid 44480873)
    • (2006) British Medical Journal , vol.332 , Issue.7550 , pp. 1115-1118
    • Costa, J.1    Borges, M.2    David, C.3    Vaz Carneiro, A.4
  • 9
    • 0017133795 scopus 로고
    • Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver
    • Hamilton RL, Williams MC, Fielding CJ, Havel RJ. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest 1976;58:667-680
    • (1976) J Clin Invest , vol.58 , pp. 667-680
    • Hamilton, R.L.1    Williams, M.C.2    Fielding, C.J.3    Havel, R.J.4
  • 10
    • 60549091035 scopus 로고    scopus 로고
    • High-density lipoproteins, inflammation and oxidative stress
    • Lond
    • Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009;116:87-98
    • (2009) Clin Sci , vol.116 , pp. 87-98
    • Tabet, F.1    Rye, K.A.2
  • 11
    • 33646409606 scopus 로고    scopus 로고
    • HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- And ABCG1-dependent pathway
    • Matsuura F, Wang N, Chen W, et al. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 2006;116:1435-1442
    • (2006) J Clin Invest , vol.116 , pp. 1435-1442
    • Matsuura, F.1    Wang, N.2    Chen, W.3
  • 12
    • 0024449985 scopus 로고
    • High-density lipoprotein - The clinical implications of recent studies
    • Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15 (Pubitemid 19267219)
    • (1989) New England Journal of Medicine , vol.321 , Issue.19 , pp. 1311-1316
    • Gordon, D.J.1    Rifkind, B.M.2
  • 13
    • 11844296800 scopus 로고    scopus 로고
    • Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: A meta-analysis of randomized controlled trials
    • DOI 10.1016/j.jacc.2004.10.031, PII S0735109704020625
    • Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005;45:185-197 (Pubitemid 40094724)
    • (2005) Journal of the American College of Cardiology , vol.45 , Issue.2 , pp. 185-197
    • Birjmohun, R.S.1    Hutten, B.A.2    Kastelein, J.J.P.3    Stroes, E.S.G.4
  • 14
    • 0023001772 scopus 로고
    • Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
    • Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986;8:1245-1255 (Pubitemid 17208898)
    • (1986) Journal of the American College of Cardiology , vol.8 , Issue.6 , pp. 1245-1255
    • Canner, P.L.1    Berge, K.G.2    Wenger, N.K.3
  • 15
    • 34447328718 scopus 로고    scopus 로고
    • Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study
    • DOI 10.1016/j.jacl.2007.05.003, PII S1933287407001407
    • Vittone F, Chait A, Morse JS, et al. Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: a Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). J Clin Lipidol 2007;1:203-210 (Pubitemid 47055291)
    • (2007) Journal of Clinical Lipidology , vol.1 , Issue.3 , pp. 203-210
    • Vittone, F.1    Chait, A.2    Morse, J.S.3    Fish, B.4    Brown, B.G.5    Zhao, X.-Q.6
  • 16
    • 10044281651 scopus 로고    scopus 로고
    • Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
    • Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-3517
    • (2004) Circulation , vol.110 , pp. 3512-3517
    • Taylor, A.J.1    Sullenberger, L.E.2    Lee, H.J.3
  • 17
    • 40649089928 scopus 로고    scopus 로고
    • Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: Magnetic resonance imaging study in an experimental model of atherosclerosis
    • Ibanez B, Vilahur G, Cimmino G, et al. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol 2008;51:1104-1109
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1104-1109
    • Ibanez, B.1    Vilahur, G.2    Cimmino, G.3
  • 20
    • 35548955508 scopus 로고    scopus 로고
    • The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials
    • DOI 10.1016/j.ahj.2007.07.011, PII S0002870307005923
    • Saha SA, Kizhakepunnur LG, Bahekar A, Arora RR. The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials. Am Heart J 2007;154:943-953 (Pubitemid 350001283)
    • (2007) American Heart Journal , vol.154 , Issue.5 , pp. 943-953
    • Saha, S.A.1    Kizhakepunnur, L.G.2    Bahekar, A.3    Arora, R.R.4
  • 21
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3
  • 22
    • 63049137529 scopus 로고    scopus 로고
    • Long-acting calcium antagonists in patients with coronary artery disease: A meta-analysis
    • Bangalore S, Parkar S, Messerli FH. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis. Am J Med 2009;122:356-365
    • (2009) Am J Med , vol.122 , pp. 356-365
    • Bangalore, S.1    Parkar, S.2    Messerli, F.H.3
  • 25
    • 54049152760 scopus 로고    scopus 로고
    • Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    • Serruys PW, Garcia-Garcia HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118:1172-1182
    • (2008) Circulation , vol.118 , pp. 1172-1182
    • Serruys, P.W.1    Garcia-Garcia, H.M.2    Buszman, P.3
  • 26
    • 53549093853 scopus 로고    scopus 로고
    • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
    • Wilensky RL, Shi Y, Mohler ER 3rd, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 2008;14:1059-1066
    • (2008) Nat Med , vol.14 , pp. 1059-1066
    • Wilensky, R.L.1    Shi, Y.2    Mohler III, E.R.3
  • 27
    • 0042510743 scopus 로고    scopus 로고
    • Inflammatory reactions in the pathogenesis of atherosclerosis
    • Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003;10:63-71
    • (2003) J Atheroscler Thromb , vol.10 , pp. 63-71
    • Fan, J.1    Watanabe, T.2
  • 28
    • 56549103855 scopus 로고    scopus 로고
    • Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: Questions and quandaries
    • Shiomi M, Fan J. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries. Curr Opin Lipidol 2008;19:631-636
    • (2008) Curr Opin Lipidol , vol.19 , pp. 631-636
    • Shiomi, M.1    Fan, J.2
  • 29
    • 42149117738 scopus 로고    scopus 로고
    • Progression and disruption of advanced atherosclerotic plaques in murine models
    • DOI 10.2174/138945008783755575
    • Rosenfeld ME, Averill MM, Bennett BJ, Schwartz SM. Progression and disruption of advanced atherosclerotic plaques in murine models. Curr Drug Targets 2008;9:210-216 (Pubitemid 351843602)
    • (2008) Current Drug Targets , vol.9 , Issue.3 , pp. 210-216
    • Rosenfeld, M.E.1    Averill, M.M.2    Bennett, B.J.3    Schwartz, S.M.4
  • 30
    • 0035480816 scopus 로고    scopus 로고
    • Lipoproteins and atherosclerosis in children: An early marriage?
    • Strong JP, Zieske AW, Malcom GT. Lipoproteins and atherosclerosis in children: an early marriage? Nutr Metab Cardiovasc Dis 2001;11(Suppl 5):16-22
    • (2001) Nutr Metab Cardiovasc Dis , vol.11 , Issue.SUPPL. 5 , pp. 16-22
    • Strong, J.P.1    Zieske, A.W.2    Malcom, G.T.3
  • 31
    • 0029151086 scopus 로고
    • A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
    • Original paper describing Stary classification for human atherosclerotic lesions
    • Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-1531 • Original paper describing Stary classification for human atherosclerotic lesions.
    • (1995) Arterioscler Thromb Vasc Biol , vol.15 , pp. 1512-1531
    • Stary, H.C.1    Chandler, A.B.2    Dinsmore, R.E.3
  • 32
    • 0028208606 scopus 로고
    • A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
    • This work describes the definition of early and intermediate atherosclerotic human lesions
    • Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840-856 • This work describes the definition of early and intermediate atherosclerotic human lesions.
    • (1994) Arterioscler Thromb , vol.14 , pp. 840-856
    • Stary, H.C.1    Chandler, A.B.2    Glagov, S.3
  • 33
    • 0019838940 scopus 로고
    • A dissecting view on the role of the fatty streak in the pathogenesis of human atherosclerosis: Culprit or bystander?
    • Modified classification of human atherosclerosis as the cause for coronary thrombosis described by our laboratory. Herein we describe erosion and nodular calcification as addition causes for thrombosis. We also define the assumed precursor lesion to plaque rupture, vulnerable plaque
    • Velican C. A dissecting view on the role of the fatty streak in the pathogenesis of human atherosclerosis: culprit or bystander? Med Intern 1981;19:321-337 • Modified classification of human atherosclerosis as the cause for coronary thrombosis described by our laboratory. Herein we describe erosion and nodular calcification as addition causes for thrombosis. We also define the assumed precursor lesion to plaque rupture, vulnerable plaque.
    • (1981) Med Intern , vol.19 , pp. 321-337
    • Velican, C.1
  • 34
    • 0034019601 scopus 로고    scopus 로고
    • Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
    • Editorial describing the role of pathological intimal thickening in coronary plaque progression
    • Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275 •• Editorial describing the role of pathological intimal thickening in coronary plaque progression.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1262-1275
    • Virmani, R.1    Kolodgie, F.D.2    Burke, A.P.3
  • 35
    • 34247356508 scopus 로고    scopus 로고
    • Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease?
    • Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 2007;27:986-989
    • (2007) Arterioscler Thromb Vasc Biol , vol.27 , pp. 986-989
    • Kolodgie, F.D.1    Burke, A.P.2    Nakazawa, G.3    Virmani, R.4
  • 38
    • 0029876139 scopus 로고    scopus 로고
    • Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death
    • This paper compares the incidence and morphological characteristics of coronary thrombosis associated with plaque rupture versus thrombosis in eroded plaques without rupture at autopsy
    • Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363 •• This paper compares the incidence and morphological characteristics of coronary thrombosis associated with plaque rupture versus thrombosis in eroded plaques without rupture at autopsy.
    • (1996) Circulation , vol.93 , pp. 1354-1363
    • Farb, A.1    Burke, A.P.2    Tang, A.L.3
  • 39
    • 0003132710 scopus 로고    scopus 로고
    • Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization
    • PII S0002934398000412
    • Libby P, Schoenbeck U, Mach F, et al. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:14S-18S (Pubitemid 28166572)
    • (1998) American Journal of Medicine , vol.104 , Issue.2 A
    • Libby, P.1    Schoenbeck, U.2    Mach, F.3    Selwyn, A.P.4    Ganz, P.5
  • 40
    • 0030961921 scopus 로고    scopus 로고
    • Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
    • Autopsy analysis of the effects of cigarette smoking and abnormal cholesterol values on coronary plaque morphology in men with coronary disease and sudden death
    • Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282 •• Autopsy analysis of the effects of cigarette smoking and abnormal cholesterol values on coronary plaque morphology in men with coronary disease and sudden death.
    • (1997) N Engl J Med , vol.336 , pp. 1276-1282
    • Burke, A.P.1    Farb, A.2    Malcom, G.T.3
  • 42
    • 0022389171 scopus 로고
    • Cholesterol and the cell membrane
    • Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985;822:267-287
    • (1985) Biochim Biophys Acta , vol.822 , pp. 267-287
    • Yeagle, P.L.1
  • 43
    • 0031899062 scopus 로고    scopus 로고
    • Physical effects of cholesterol on arterial smooth muscle membranes: Evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis
    • Tulenko TN, Chen M, Mason PE, Mason RP. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J Lipid Res 1998;39:947-956 (Pubitemid 28221998)
    • (1998) Journal of Lipid Research , vol.39 , Issue.5 , pp. 947-956
    • Tulenko, T.N.1    Chen, M.2    Mason, P.E.3    Mason, R.P.4
  • 44
    • 0344235454 scopus 로고    scopus 로고
    • Intraplaque hemorrhage and progression of coronary atheroma
    • This paper examines the role of intraplaque hemorrhage in coronary plaque progression in a large series of patients with sudden coronary death
    • Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325 •• This paper examines the role of intraplaque hemorrhage in coronary plaque progression in a large series of patients with sudden coronary death.
    • (2003) N Engl J Med , vol.349 , pp. 2316-2325
    • Kolodgie, F.D.1    Gold, H.K.2    Burke, A.P.3
  • 45
    • 34248639027 scopus 로고    scopus 로고
    • Elimination of neoangiogenesis for plaque stabilization: Is there a role for local drug therapy?
    • Kolodgie FD, Narula J, Yuan C, et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol 2007;49:2093-2101
    • (2007) J Am Coll Cardiol , vol.49 , pp. 2093-2101
    • Kolodgie, F.D.1    Narula, J.2    Yuan, C.3
  • 48
    • 27644537437 scopus 로고    scopus 로고
    • Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic efficiency
    • Review of the role and mechanisms of macrophage apoptosis in atherosclerosis
    • Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 2005;25:2255-2264 • Review of the role and mechanisms of macrophage apoptosis in atherosclerosis.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 2255-2264
    • Tabas, I.1
  • 50
    • 0032842812 scopus 로고    scopus 로고
    • Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption
    • Autopsy analysis demonstrating the role of subclinical plaque disruption and healing in plaque growth
    • Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265-268 • Autopsy analysis demonstrating the role of subclinical plaque disruption and healing in plaque growth.
    • (1999) Heart , vol.82 , pp. 265-268
    • Mann, J.1    Davies, M.J.2
  • 51
    • 0035916310 scopus 로고    scopus 로고
    • Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression
    • Autopsy analysis examining the role of silent plaque rupture and healing as a cause of progressive luminal stenosis
    • Burke AP, Kolodgie FD, Farb A, et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940 • Autopsy analysis examining the role of silent plaque rupture and healing as a cause of progressive luminal stenosis.
    • (2001) Circulation
    • Burke, A.P.1    Kolodgie, F.D.2    Farb, A.3
  • 52
    • 0037926586 scopus 로고    scopus 로고
    • 34th Bethesda Conference: Task force #2-what is the pathologic basis for new atherosclerosis imaging techniques?
    • Review of the most important pathologic feature of vulnerable plaque that might be amenable to imaging
    • Burke AP, Virmani R, Galis Z, et al. 34th Bethesda Conference: task force #2-what is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol 2003;41:1874-1886 • Review of the most important pathologic feature of vulnerable plaque that might be amenable to imaging.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1874-1886
    • Burke, A.P.1    Virmani, R.2    Galis, Z.3
  • 56
    • 0031937705 scopus 로고    scopus 로고
    • Animal models of atherosclerosis and interpretation of drug intervention studies
    • Bocan TM. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr Pharm Des 1998;4:37-52 (Pubitemid 28090067)
    • (1998) Current Pharmaceutical Design , vol.4 , Issue.1 , pp. 37-52
    • Bocan, T.M.A.1
  • 58
    • 0028853846 scopus 로고
    • Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits
    • Shiomi M, Ito T, Tsukada T, et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995;15:1938-1944
    • (1995) Arterioscler Thromb Vasc Biol , vol.15 , pp. 1938-1944
    • Shiomi, M.1    Ito, T.2    Tsukada, T.3
  • 59
    • 0032560637 scopus 로고    scopus 로고
    • Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization
    • This paper demonstrates that lipid lowering by diet in the rabbit atheroscerlotic model reduces expression of enzymes that degrade extracellular matrix and thereby stabilizes plaques
    • Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998;97:2433-2444 • This paper demonstrates that lipid lowering by diet in the rabbit atheroscerlotic model reduces expression of enzymes that degrade extracellular matrix and thereby stabilizes plaques.
    • (1998) Circulation , vol.97 , pp. 2433-2444
    • Aikawa, M.1    Rabkin, E.2    Okada, Y.3
  • 60
    • 0035916305 scopus 로고    scopus 로고
    • Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits
    • Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001;103:993-999 (Pubitemid 32183806)
    • (2001) Circulation , vol.103 , Issue.7 , pp. 993-999
    • Fukumoto, Y.1    Libby, P.2    Rabkin, E.3    Hill, C.C.4    Enomoto, M.5    Hirouchi, Y.6    Shiomi, M.7    Aikawa, M.8
  • 61
    • 0032538870 scopus 로고    scopus 로고
    • Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma
    • Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998;83:1015-1026 (Pubitemid 28520931)
    • (1998) Circulation Research , vol.83 , Issue.10 , pp. 1015-1026
    • Aikawa, M.1    Rabkin, E.2    Voglic, S.J.3    Shing, H.4    Nagai, R.5    Schoen, F.J.6    Libby, P.7
  • 64
    • 0027976942 scopus 로고
    • Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
    • Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994;14:141-147
    • (1994) Arterioscler Thromb , vol.14 , pp. 141-147
    • Reddick, R.L.1    Zhang, S.H.2    Maeda, N.3
  • 65
    • 0034807277 scopus 로고    scopus 로고
    • Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice
    • DOI 10.1002/path.915
    • Calara F, Silvestre M, Casanada F, et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 2001;195:257-263 (Pubitemid 32899037)
    • (2001) Journal of Pathology , vol.195 , Issue.2 , pp. 257-263
    • Calara, F.1    Silvestre, M.2    Casanada, F.3    Yuan, N.4    Napoli, C.5    Palinski, W.6
  • 69
    • 0031445149 scopus 로고    scopus 로고
    • Attenuation of plasma low density lipoprotein cholesterol by select 3- Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in mice devoid of low density lipoprotein receptors
    • Bisgaier CL, Essenburg AD, Auerbach BJ, et al. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. J Lipid Res 1997;38:2502-2515 (Pubitemid 28028135)
    • (1997) Journal of Lipid Research , vol.38 , Issue.12 , pp. 2502-2515
    • Bisgaier, C.L.1    Essenburg, A.D.2    Auerbach, B.J.3    Pape, M.E.4    Sekerke, C.S.5    Gee, A.6    Wolle, S.7    Newton, R.S.8
  • 71
    • 0036645435 scopus 로고    scopus 로고
    • Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids
    • DOI 10.1161/01.CIR.0000022843.76104.01
    • Chen Z, Fukutomi T, Zago AC, et al. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 2002;106:20-23 (Pubitemid 34747436)
    • (2002) Circulation , vol.106 , Issue.1 , pp. 20-23
    • Chen, Z.1    Fukutomi, T.2    Zago, A.C.3    Ehlers, R.4    Detmers, P.A.5    Wright, S.D.6    Rogers, C.7    Simon, D.I.8
  • 72
    • 0028268018 scopus 로고
    • The two-receptor model of lipoprotein clearance: Tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
    • Ishibashi S, Herz J, Maeda N, et al. The two-receptor model of lipoprotein clearance: tests of the hypothesis in 'knockout' mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 1994;91:4431-4435
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 4431-4435
    • Ishibashi, S.1    Herz, J.2    Maeda, N.3
  • 73
    • 40649124979 scopus 로고    scopus 로고
    • Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice
    • Nachtigal P, Pospisilova N, Jamborova G, et al. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Life Sci 2008;82:708-717
    • (2008) Life Sci , vol.82 , pp. 708-717
    • Nachtigal, P.1    Pospisilova, N.2    Jamborova, G.3
  • 75
    • 0033015655 scopus 로고    scopus 로고
    • Role of apoCs in lipoprotein metabolism: Functional differences between ApoC1, ApoC2, and ApoC3
    • Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999;19:472-484 (Pubitemid 29135144)
    • (1999) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.19 , Issue.3 , pp. 472-484
    • Jong, M.C.1    Hofker, M.H.2    Havekes, L.M.3
  • 76
    • 34547624651 scopus 로고    scopus 로고
    • Mouse models for atherosclerosis and pharmaceutical modifiers
    • Review of mouse models of atherosclerosis and the effect of different pharmacologic agents for
    • Zadelaar S, Kleemann R, Verschuren L, et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007;27:1706-1721 • Review of mouse models of atherosclerosis and the effect of different pharmacologic agents for
    • (2007) Arterioscler Thromb Vasc Biol , vol.27 , pp. 1706-1721
    • Zadelaar, S.1    Kleemann, R.2    Verschuren, L.3
  • 77
    • 2542465868 scopus 로고    scopus 로고
    • Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
    • DOI 10.1182/blood-2003-11-3791
    • Kleemann R, Verschuren L, de Rooij BJ, et al. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 2004;103:4188-4194 (Pubitemid 38685361)
    • (2004) Blood , vol.103 , Issue.11 , pp. 4188-4194
    • Kleemann, R.1    Verschuren, L.2    De Rooij, B.-J.3    Lindeman, J.4    De Maat, M.M.5    Szalai, A.J.6    Princen, H.M.G.7    Kooistra, T.8
  • 78
    • 39749145196 scopus 로고    scopus 로고
    • Translating molecular discoveries into new therapies for atherosclerosis
    • Review discussing how to translate molecular insights into atherosclerosis into new therapies
    • Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008;451:904-913 • Review discussing how to translate molecular insights into atherosclerosis into new therapies.
    • (2008) Nature , vol.451 , pp. 904-913
    • Rader, D.J.1    Daugherty, A.2
  • 79
    • 0031138861 scopus 로고    scopus 로고
    • The composition of coronary-artery plaques
    • Davies MJ. The composition of coronary-artery plaques. N Engl J Med 1997;336:1312-1314
    • (1997) N Engl J Med , vol.336 , pp. 1312-1314
    • Davies, M.J.1
  • 80
    • 0029090411 scopus 로고
    • Coronary plaque disruption
    • Review of the role of coronary plaque disruption on atherosclerosis
    • Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671 •• Review of the role of coronary plaque disruption on atherosclerosis.
    • (1995) Circulation , vol.92 , pp. 657-671
    • Falk, E.1    Shah, P.K.2    Fuster, V.3
  • 82
    • 0037420492 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
    • DOI 10.1016/S0140-6736(03)12948-0
    • Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158 (Pubitemid 36398384)
    • (2003) Lancet , vol.361 , Issue.9364 , pp. 1149-1158
    • Sever, P.S.1    Dahlof, B.2    Poulter, N.R.3    Wedel, H.4    Beevers, G.5    Caulfield, M.6    Collins, R.7    Kjeldsen, S.E.8    Kristinsson, A.9    McInnes, G.T.10    Mehlsen, J.11    Nieminen, M.12    O'Brien, E.13    Ostergren, J.14
  • 84
    • 0037132607 scopus 로고    scopus 로고
    • Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
    • Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007
    • (2002) JAMA , vol.288 , pp. 2998-3007
  • 85
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
    • DOI 10.1016/S0140-6736(02)09327-3
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22 (Pubitemid 34756487)
    • (2002) Lancet , vol.360 , Issue.9326 , pp. 7-22
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleight, P.4    Peto, R.5
  • 86
    • 33744960230 scopus 로고    scopus 로고
    • Effect of ACAT inhibition on the progression of coronary atherosclerosis: A randomized controlled trial
    • Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-1565 (Pubitemid 43853488)
    • (2006) ACC Cardiosource Review Journal , vol.15 , Issue.5 , pp. 95-96
    • Nissen, S.E.1    Michelson, E.L.2
  • 89
    • 39249083201 scopus 로고    scopus 로고
    • Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial
    • Underhill HR, Yuan C, Zhao XQ, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008;155:584 e1-8
    • (2008) Am Heart J , vol.155
    • Underhill, H.R.1    Yuan, C.2    Zhao, X.Q.3
  • 90
    • 0025121280 scopus 로고
    • Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest
    • DOI 10.1016/0002-9149(90)90482-G
    • Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 1990;66:562-567 (Pubitemid 20292512)
    • (1990) American Journal of Cardiology , vol.66 , Issue.5 , pp. 562-567
    • Kragel, A.H.1    Reddy, S.G.2    Wittes, J.T.3    Roberts, W.C.4
  • 95
    • 0035916233 scopus 로고    scopus 로고
    • Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization
    • Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001;103:926-933 (Pubitemid 32183796)
    • (2001) Circulation , vol.103 , Issue.7 , pp. 926-933
    • Crisby, M.1    Nordin-Fredriksson, G.2    Shah, P.K.3    Yano, J.4    Zhu, J.5    Nilsson, J.6
  • 96
    • 58849102557 scopus 로고    scopus 로고
    • Carotid atherosclerotic plaques stabilize after stroke: Insights into the natural process of atherosclerotic plaque stabilization
    • This paper examines the pathophysiology of lesion stabilization after symptomatic stroke in a large series of carotid endarterectomies
    • Peeters W, Hellings WE, de Kleijn DP, et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009;29:128-133 •• This paper examines the pathophysiology of lesion stabilization after symptomatic stroke in a large series of carotid endarterectomies.
    • (2009) Arterioscler Thromb Vasc Biol , vol.29 , pp. 128-133
    • Peeters, W.1    Hellings, W.E.2    De Kleijn, D.P.3
  • 97
    • 14844335659 scopus 로고    scopus 로고
    • Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients
    • Hsu HY, Wang PY, Chen YT, et al. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients. J Chin Med Assoc 2005;68:53-58 (Pubitemid 40347993)
    • (2005) Journal of the Chinese Medical Association , vol.68 , Issue.2 , pp. 53-58
    • Hsu, H.-Y.1    Wang, P.-Y.2    Chen, Y.-T.3    Sheu, W.H.-H.4    Hu, H.-H.5    Sheng, W.-Y.6
  • 99
    • 56249127895 scopus 로고    scopus 로고
    • Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk
    • Forst T, Wilhelm B, Pfutzner A, et al. Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk. Diab Vasc Dis Res 2008;5:298-303
    • (2008) Diab Vasc Dis Res , vol.5 , pp. 298-303
    • Forst, T.1    Wilhelm, B.2    Pfutzner, A.3
  • 101
    • 61749103652 scopus 로고    scopus 로고
    • CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima
    • Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009;119:136-145
    • (2009) J Clin Invest , vol.119 , pp. 136-145
    • Park, Y.M.1    Febbraio, M.2    Silverstein, R.L.3
  • 102
    • 3042613500 scopus 로고    scopus 로고
    • Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively
    • DOI 10.1016/j.amjcard.2004.03.050, PII S0002914904004643
    • Molloy KJ, Thompson MM, Schwalbe EC, et al. Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol 2004;94:144-146 (Pubitemid 38813475)
    • (2004) American Journal of Cardiology , vol.94 , Issue.1 , pp. 144-146
    • Molloy, K.J.1    Thompson, M.M.2    Schwalbe, E.C.3    Bell, P.R.F.4    Naylor, A.R.5    Loftus, I.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.